Phosphorylation of the liver X receptors

FEBS Letters

Volumn 580, Issue 20, 2006, Pages 4835-4841

  Chen, Mingyi ^a   Bradley, Michelle N ^a   Beaven, Simon W ^a   Tontonoz, Peter ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholesterol metabolism; Liver X receptor; Phosphorylation

Indexed keywords

LIGAND; LIVER X RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN; SERINE;

ARTICLE; CELL METABOLISM; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; LIVER; MUTATIONAL ANALYSIS; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CELL LINE; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; GENES, REPORTER; HUMANS; MICE; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RECEPTORS, CYTOPLASMIC AND NUCLEAR; SERINE; SIGNAL TRANSDUCTION;

EID: 33747867030     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.07.074     Document Type: Article

References (25)

1. Beaven S.W., and Tontonoz P. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu. Rev. Med. 57 (2006) 313-329
2. Tontonoz P., and Mangelsdorf D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17 (2003) 985-993
3. Janowski B.A., Willy P.J., Rama-Devi T., Falck J.R., and Mangelsdorf D.J. An oxysterol signaling pathway mediated by the nuclear receptor LXRα. Nature. 383 (1996) 728-731
4. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.L., Sundseth S.S., Winegar D.A., Blanchard D.E., Spencer T.A., and Willson T.M. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272 (1997) 3137-3140
5. Venkateswaran A., Laffitte B.A., Joseph S.B., Mak P.A., Wilpitz D.C., Edwards P.A., and Tontonoz P. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA 97 (2000) 12097-12102
6. Peet D.J., Turley S.D., Ma W., Janowski B.A., Lobaccaro J.M., Hammer R.E., and Mangelsdorf D.J. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93 (1998) 693-704
7. Joseph S.B., Castrillo A., Laffitte B.A., Mangelsdorf D.J., and Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9 (2003) 213-219
8. Liang G., Yang J., Horton J.D., Hammer R.E., Goldstein J.L., and Brown M.S. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277 (2002) 9520-9528
9. Joseph S.B., Lafitte B.A., Patel P.H., Watson M.A., Matsukuma K.E., Walczak R., Collins J.L., Osborne T.F., and Tontonoz P. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J. Biol. Chem. 277 (2002) 11019-11025
10. Joseph S.B., McKilligin E., Pei L., Watson M.A., Collins A.R., Laffitte B.A., Chen M., Noh G., Goodman J., Hagger G.N., et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 99 (2002) 7604-7609
11. Tangirala R.K., Bischoff E.D., Joseph S.B., Wagner B.L., Walczak R., Laffitte B.A., Daige C.L., Thomas D., Heyman R.A., Mangelsdorf D.J., et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc. Natl. Acad. Sci. USA 99 (2002) 11896-11901
12. Hu E., Kim J.B., Sarraf P., and Spiegelman B.M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274 (1996) 2100-2103
13. Shalev A., Siegrist-Kaiser C.A., Yen P.A., Wahli W., Burger A.G., Chin W.W., and Meier C.A. The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 137 (1996) 4499-4502
14. Zhang B., Berger J., Zhou G., Elbrecht A., Biswas S., White-Carrington S., Szalkowski D., and Moller D.E. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 271 (1996) 31771-31774
15. Rousseau G.G. Structure and regulation of the glucocorticoid hormone receptor. Mol. Cell. Endocrinol. 38 (1984) 1-11
16. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., and Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 (1995) 1491-1494
17. Denner L.A., Weigel N.L., Maxwell B.L., Schrader W.T., and O'Malley B.W. Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250 (1990) 1740-1743
18. Chen M., Beaven S.W., and Tontonoz P. Identification and characterization of two alternatively spliced transcript variants of human liver X receptor alpha. J. Lipid Res. 46 (2005) 2570-2579
19. Laffitte B.A., Joseph S.B., Walczak R., Pei L., Wilpitz D.C., Collins J.L., and Tontonoz P. Autoregulation of the human liver X receptor alpha promoter. Mol. Cell. Biol. 21 (2001) 7558-7568
20. Joseph S.B., Bradley M.N., Castrillo A., Bruhn K.W., Mak P.A., Pei L., Hogenesch J., O'Connell R.M., Cheng G., Saez E., Miller J., and Tontonoz P. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119 (2004) 299-309
21. Rosenfeld M.G., Lunyak V.V., and Glass C.K. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20 (2006) 1405-1428
22. Lee Y.K., Choi Y.H., Chua S., Park Y.J., and Moore D.D. Phosphorylation of the hinge domain of the nuclear hormone receptor LRH-1 stimulates transactivation. J. Biol. Chem. 281 (2006) 7850-7855
23. Orti E., Bodwell J.E., and Munck A. Phosphorylation of steroid hormone receptors. Endocr. Rev. 13 (1992) 105-128
24. Blanquart C., Mansouri R., Paumelle R., Fruchart J.C., Staels B., and Glineur C. The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha. Mol. Endocrinol. 18 (2004) 1906-1918
25. Lazennec G., Canaple L., Saugy D., and Wahli W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol. Endocrinol. 14 (2000) 1962-1975